Capital Increase in Genmab A/S as a Result of Employee Warrant Exercise

Published: Nov 15, 2012

Copenhagen, Denmark; November 14, 2012 – Genmab A/S (OMX: GEN) will increase its share capital by 750 shares as a consequence of the exercise of employee warrants.

The increase is effected without any preemption rights for the existing shareholders of the company or others. The shares are subscribed in cash at the following price per share of nominally DKK 1: 750 shares at DKK 67.50. Proceeds to the company are DKK 50,625 (approx. USD 8,600). The increase corresponds to approx. 0.001 % of the company’s share capital.

Back to news